Clinical Trials Directory

Trials / Completed

CompletedNCT04273022

Effect of Exercise on Biomarkers in SCT

The Effect of Exercise on Resting Biomarkers in Subjects With Sickle Cell Trait

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
St. Louis University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

This study measures the effect of exercise on a variety of biomarkers in blood and urine selected to evaluate the physiological pathways of hemolysis, myolysis, thrombosis, inflammation, and renal function in subjects with sickle cell trait. These pathways have been shown to be associated with adverse events in athletes and warfighters with SCT upon protracted, repeated, strenuous exertion. Changes in biomarkers post-exercise compared to pre-exercise (and compared to healthy controls) suggest activation of the associated pathway(s) which may contribute to exercise-related events in athletes and warfighters and subclinical complications in non-athletes.

Detailed description

Subjects with sickle cell trait and healthy controls will be subjected to a single bout of moderate, controlled exercise on a treadmill. Blood and urine samples will be collected before exercise, immediately after exercise, and 24 hours after exercise. Fifteen biomarkers, three selected to evaluate each of the five physiologic pathways previously listed, will be tested at each of the three time points. Abnormal biomarkers before exercise suggest chronic pathway activation while exacerbated levels after exercise suggest further activation stimulated by exercise. Biomarker levels 24 hours post-exercise will be used to evaluate continued pathway activation or pathway recovery. By definition, 95% of health controls will show normal biomarker levels pre-exercise and biomarker patterns post-exercise will serve as the expected standard by which to compare the test subjects.

Conditions

Interventions

TypeNameDescription
OTHERExerciseA single bout of standardized, moderate exercise

Timeline

Start date
2021-12-27
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2020-02-17
Last updated
2025-01-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04273022. Inclusion in this directory is not an endorsement.